These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


376 related items for PubMed ID: 22248200

  • 1. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP, Chan KC, Yan WW.
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [Abstract] [Full Text] [Related]

  • 2. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 3. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
    Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB.
    Blood Purif; 2007 Oct; 25(4):316-23. PubMed ID: 17700015
    [Abstract] [Full Text] [Related]

  • 4. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D, Ramganesh S, Richardson R, Mehta S, Lapinsky SE.
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [Abstract] [Full Text] [Related]

  • 5. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A, Ross EA.
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [Abstract] [Full Text] [Related]

  • 6. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S.
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [Abstract] [Full Text] [Related]

  • 7. The use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenation.
    Shum HP, Kwan AM, Chan KC, Yan WW.
    ASAIO J; 2014 Dec; 60(4):413-8. PubMed ID: 24727536
    [Abstract] [Full Text] [Related]

  • 8. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D.
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [Abstract] [Full Text] [Related]

  • 9. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
    Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A.
    BMC Nephrol; 2013 Oct 25; 14():232. PubMed ID: 24156306
    [Abstract] [Full Text] [Related]

  • 10. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R, Niles JL.
    Kidney Int; 1999 May 25; 55(5):1991-7. PubMed ID: 10231464
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration.
    Hetzel GR, Taskaya G, Sucker C, Hennersdorf M, Grabensee B, Schmitz M.
    Am J Kidney Dis; 2006 Nov 25; 48(5):806-11. PubMed ID: 17060000
    [Abstract] [Full Text] [Related]

  • 16. Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution.
    Jeffrey YH, Hoi-Ping S, Kit Hung AL, Chung-Ling L, Wing-Wa Y, King-Yiu L.
    Indian J Crit Care Med; 2017 Jan 25; 21(1):11-16. PubMed ID: 28197045
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S, Haase M, Ruckert M, Krieg H, Kastrup M, Krausch D, Vargas-Hein O, Zuckermann-Becker H, Peters H, Pohlmeier R, Neumayer HH.
    Nephron Clin Pract; 2005 Jan 25; 101(4):c211-9. PubMed ID: 16155399
    [Abstract] [Full Text] [Related]

  • 20. A retrospective review of the use of regional citrate anticoagulation in continuous venovenous hemofiltration for critically ill patients.
    Leung AK, Shum HP, Chan KC, Chan SC, Lai KY, Yan WW.
    Crit Care Res Pract; 2013 Jan 25; 2013():349512. PubMed ID: 23424680
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.